A global treatments for coronaviruses including COVID‐19
Abstract In late December 2019 in Wuhan, China, several patients with viral pneumonia
were identified as 2019 novel coronavirus (2019‐nCoV). So far, there are no specific …
were identified as 2019 novel coronavirus (2019‐nCoV). So far, there are no specific …
[HTML][HTML] An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics
D Wang, Z Li, Y Liu - Journal of infection and public health, 2020 - Elsevier
Since a novel coronavirus pneumonia outbreak in late December 2019, coronavirus disease-
19 (COVID-19) epidemic has gradually spread worldwide, becoming a major public health …
19 (COVID-19) epidemic has gradually spread worldwide, becoming a major public health …
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status
YR Guo, QD Cao, ZS Hong, YY Tan, SD Chen… - Military medical …, 2020 - Springer
An acute respiratory disease, caused by a novel coronavirus (SARS-CoV-2, previously
known as 2019-nCoV), the coronavirus disease 2019 (COVID-19) has spread throughout …
known as 2019-nCoV), the coronavirus disease 2019 (COVID-19) has spread throughout …
COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
Y Song, M Zhang, L Yin, K Wang, Y Zhou… - International journal of …, 2020 - Elsevier
Currently, there is no approved therapy for coronavirus disease 2019 (COVID-19). The
World Health Organization (WHO) therefore endorses supportive care only. However …
World Health Organization (WHO) therefore endorses supportive care only. However …
[HTML][HTML] SARS‐CoV‐2 virus infection: targets and antiviral pharmacological strategies
DM de Oliveira Campos, UL Fulco… - Journal of evidence …, 2020 - ncbi.nlm.nih.gov
The current pandemic of coronavirus disease 2019 (COVID-19) poses a threat to global
public health owing to its high rate of spread and its association with severe forms of …
public health owing to its high rate of spread and its association with severe forms of …
Advances in the possible treatment of COVID-19: A review.
P Chibber, SA Haq, I Ahmed, NI Andrabi… - European journal of …, 2020 - Elsevier
The emergence of the global pandemic caused by novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …
An update on current therapeutic drugs treating COVID-19
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
Efficacy of the current investigational drugs for the treatment of COVID-19: a scoping review
To date, there is no final FDA-approved treatment for COVID-19. There are thousands of
studies published on the available treatments for COVID-19 virus in the past year. Therefore …
studies published on the available treatments for COVID-19 virus in the past year. Therefore …
Emerging treatment strategies for COVID-19 infection
M Gavriatopoulou, I Ntanasis-Stathopoulos… - Clinical and …, 2021 - Springer
The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …
Recent progress of antiviral therapy for coronavirus disease 2019
M Zhao, J Zhang, H Li, Z Luo, J Ye, Y Xu… - European journal of …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic has become a global public
health crisis, for which antiviral treatments are considered mainstream therapeutic …
health crisis, for which antiviral treatments are considered mainstream therapeutic …